Career   |   Back Office   |   FAQs   |   Business Associates   |   Feedback/Grievance   |   Sitemap
 
BSE Announcements
NSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
Name Change
De-Listed Shares
Split Of Face Value
Market Turnover
BSE Announcements  
ACC  [21-Feb-2020]
The Board of ACC at its meeting held on 20 February 2020 has approved the following -

Neeraj Akhoury, Managing Director & Chief Executive Officer of the Company has tendered his resignation from the post of MD&CEO with effect from close of business hours of 20 February 2020.

Christof W. Hassig has tendered his resignation from the directorship of the Company with immediate effect.

Sridhar Balakrishnan (DIN: 0008699523), Chief Commercial Officer of the Company has been appointed as an Additional Director on the Board of the Company with immediate effect.

Sridhar Balakrishnan has been appointed as Managing Director & Chief Executive Officer of the Company for the period of 5 years with effect from 21 February 2020.

Ambuja Cem.  [21-Feb-2020]
The Board of Ambuja Cement at its meeting held on 20 February 2020 has approved the following change in directorate -

Resignation of Bimlendra Jha, MD & CEO of the company with effect from 20 February 2020.

Appointment of Neeraj Akhoury as the new MD & CEO of the Company w.e.f. 21 February 2020.

Dr Reddy's Labs  [21-Feb-2020]
Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) from USFDA, for the company's formulations manufacturing facility at Duvvada, Visakhapatnam (Vizag SEZ Plant 1- FTO 7), indicating closure of the audit. As intimated earlier the facility has been classified as V AI (Voluntary Action Indicated).
Prev   | Next 
Designed, developed & maintained by CMOTS INFOTECH (ISO 9001:2015 certified).